Published in Am J Health Syst Pharm on February 01, 2009
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. PLoS Negl Trop Dis (2010) 1.30
A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection. Antimicrob Agents Chemother (2010) 1.22
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother (2009) 1.00
Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity. Mol Pharm (2009) 0.85
Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis. Antimicrob Agents Chemother (2009) 0.80
Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer. Ann Pharmacother (2013) 0.78
Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan. J Clin Microbiol (2010) 0.77
Fusarium peritonitis successfully managed with posaconazole and catheter removal. Perit Dial Int (2014) 0.77
Posaconazole treatment in Korea: single-center experience over 5 years. Yonsei Med J (2013) 0.75